(505) 254-7784 pchelp@pcsanm.org
  • About Us
    • Mission Statement
    • Our Board
    • Organization Description
  • Contact Us
  • Donate Today!
0 Items
Prostate Cancer Support Association of New Mexico
  • Home
  • Start Here
    • Beginner’s Guide
    • Next Steps
  • Meetings
  • Resources
  • Education & Info
    • Helpful Prostate Cancer-Related Websites
    • NM Cancer Resources & Support
    • News You Can Use
    • Articles of Interest
    • For Medical Professionals
  • Annual Conference
  • Newsletters
  • Early Detection
    • Early Detection
    • Free PSA Test
Select Page

Recent ARCHES Data in Men with Metastatic Hormone-Sensitive Prostate Cancer

by admin_63069 | Jun 15, 2022 | News You Can Use

In this video, Andrew J. Armstrong, MD, MSc, discusses new data from the ARCHES trial

Updates of Androgen Deprivation Therapy

by admin_63069 | Jun 11, 2022 | News You Can Use

Expert panelists center discussion around two patient cases to review use of newer anti-androgen deprivation therapy in the management of prostate cancer.

Molecular Testing and Unmet Needs in Prostate Cancer

by admin_63069 | Jun 7, 2022 | News You Can Use

In this interview, Stephen J. Savage, MD, discusses current research he’s working on, the role of molecular testing in prostate cancer as well as unmet needs in treating the disease. 

Negative MRI in Active Surveillance Often Predicts Stable Prostate Cancer

by admin_63069 | Jun 3, 2022 | News You Can Use

A majority of subsequent biopsies performed in men with negative mpMRI results showed tumors of equal or lesser grade.

PSA Bounce vs Biochemical Recurrence After Prostate Cancer SBRT Probed

by admin_63069 | May 30, 2022 | News You Can Use

In a study, men with PSA bounce had a lower PSA nadir and longer time to PSA nadir than men who had biochemical recurrence.

The Efficacy of Sabizabulin in Prostate Cancer

by admin_63069 | May 27, 2022 | News You Can Use

Mark C. Markowski, MD, PhD, discusses the safety and efficacy of sabizabulin in a phase 1b/2 trial in metastatic castration-resistant prostate cancer.
« Older Entries
Next Entries »

What’s New

  • Key Prostate Cancer Research
  • Cohort Study Identified Optimal Minimum Treatment Duration for ADT in High-Risk Prostate Cancer
  • MRI-Guided HIFU Effective in Intermediate-Risk Prostate Cancer
  • The Future of Metastatic Prostate Cancer Management
  • Researchers Uncover Mechanism By Which Prostate Cancer Becomes Resistant

Disclaimers:

PCSANM provides education, information, and support, not medical advice. Please contact your physician for all your medical concerns. No copyrighted material belonging to others is knowingly used without permission. If any is inadvertently used without permission, please contact our office. Articles are selected from a variety of sources to give as wide a range of content as possible. PCSANM does not endorse or approve, and assumes no responsibility for, the content, accuracy, or completeness of the information presented.

2533 Virginia St. NE, Suite C Albuquerque, NM 87110

Phone: (505) 254-7784
Toll Free: (800) 278-7678
Fax: (505) 254-7786

Email: pchelp@pcsanm.org